Maxygen (2)

Executive Summary

Maxygen is a privately held biotechnology company based in Redwood City, California, founded in 1997. It specializes in directed evolution and protein engineering through its proprietary molecular breeding technology, which generates libraries of genetic diversity with high functional content. Despite its early pioneering role in the field, Maxygen has remained private and has not publicly disclosed a product pipeline or recent funding rounds as of early 2026. The company's long history and lack of recent public updates suggest it may be operating at a lower profile, potentially focusing on platform licensing or internal R&D without immediate clinical-stage assets.